{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:26:06Z","timestamp":1788791166029,"version":"build-2803163510"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK140275"],"award-info":[{"award-number":["DK140275"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012483","name":"University of Georgia Office of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Appetite"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.appet.2026.108729","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:19:37Z","timestamp":1785194377000},"page":"108729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period"],"prefix":"10.1016","volume":"227","author":[{"given":"Austin M.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-031X","authenticated-orcid":false,"given":"Emily E.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08998280.2025.2456441","article-title":"Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: A systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Abdrabou Abouelmagd","year":"2025","journal-title":"Proceedings (Baylor University. Medical Center)"},{"key":"10.1016\/j.appet.2026.108729_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/DMSO.S387116","article-title":"The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: Systematic review of randomized controlled trials","volume":"16","author":"Aldawsari","year":"2023","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"8","key":"10.1016\/j.appet.2026.108729_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tcm.2024.03.003","article-title":"The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action","volume":"34","author":"Alexiadou","year":"2024","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib6","doi-asserted-by":"crossref","first-page":"CD012691","DOI":"10.1002\/14651858.CD012691","article-title":"Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years","volume":"2017","author":"Al\u2010Khudairy","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1037\/pha0000620","article-title":"Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice","volume":"31","author":"Allingbjerg","year":"2023","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.appet.2026.108729_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.physbeh.2014.02.026","article-title":"Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior","volume":"136","author":"Anderberg","year":"2014","journal-title":"Physiology & Behavior"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/brainsci13111503","article-title":"GLP-1 receptor agonists and related mental health issues; insights from a range of social media platforms using a mixed-methods approach","volume":"13","author":"Arillotta","year":"2023","journal-title":"Brain Sciences"},{"issue":"9","key":"10.1016\/j.appet.2026.108729_bib9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc19-0749","article-title":"Pioneer 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes","volume":"42","author":"Aroda","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.appet.2026.108729_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114622","article-title":"Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review","volume":"283","author":"Badulescu","year":"2024","journal-title":"Physiology & Behavior"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4093\/dmj.2019.0018","article-title":"Glucagon-like Peptide-1 receptor agonist differentially affects brain activation in response to visual food cues in lean and Obese individuals with type 2 diabetes mellitus","volume":"44","author":"Bae","year":"2020","journal-title":"Diabetes & Metabolism Journal"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib12","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1359\/jbmr.2000.15.11.2245","article-title":"Calcium accretion in girls and boys during puberty: A longitudinal analysis","volume":"15","author":"Bailey","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"issue":"23","key":"10.1016\/j.appet.2026.108729_bib13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa072515","article-title":"Childhood body-mass index and the risk of coronary heart disease in adulthood","volume":"357","author":"Baker","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70262","article-title":"GLP\u20101 agonists for pediatric psychopharmacology: Opportunities and cautions","volume":"18","author":"Bartkoski","year":"2025","journal-title":"Clinical and Translational Science"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/oby.2004.39","article-title":"Cognitive change in Obese adolescents losing weight","volume":"12","author":"Barton","year":"2004","journal-title":"Obesity Research"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.15537\/1658-3175.6088","article-title":"Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes","volume":"35","author":"Bashier","year":"2014","journal-title":"Saudi Medical Journal"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/acsmedchemlett.8b00226","article-title":"Chemical strategies for half-life extension of biopharmaceuticals: Lipidation and its alternatives","volume":"9","author":"Bech","year":"2018","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/j.appet.2026.108729_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103711","article-title":"Adolescent to adulthood weight trajectories and the risk of obesity-related cancers, overall and early-onset: A population-based cohort study","volume":"91","author":"Bendor","year":"2026","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41366-024-01500-y","article-title":"Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: Techniques and opportunities","volume":"49","author":"Bettadapura","year":"2025","journal-title":"International Journal of Obesity"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13679-023-00549-6","article-title":"Body composition changes in adolescents who underwent bariatric surgery: A systematic review and meta-analysis","volume":"13","author":"Bezerra","year":"2024","journal-title":"Current Obesity Reports"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jesf.2014.04.001","article-title":"Obese adolescents who gained\/maintained or lost weight had similar body composition and cardiometabolic risk factors following a multidisciplinary intervention","volume":"12","author":"Bianchini","year":"2014","journal-title":"Journal of Exercise Science & Fitness"},{"issue":"14","key":"10.1016\/j.appet.2026.108729_bib22","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMoa1713231","article-title":"Change in overweight from childhood to early adulthood and risk of type 2 diabetes","volume":"378","author":"Bjerregaard","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.appet.2026.108729_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/archdischild-2023-326687","article-title":"Semaglutide treatment for children with obesity: An observational study","volume":"109","author":"Boxel","year":"2024","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl. 2","key":"10.1016\/j.appet.2026.108729_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000182594","article-title":"Growth hormone and insulin interactions","volume":"38","author":"Caprio","year":"2008","journal-title":"Hormone Research"},{"issue":"21","key":"10.1016\/j.appet.2026.108729_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160854","article-title":"\u03b2 cell mass expansion during puberty involves serotonin signaling and determines glucose homeostasis in adulthood","volume":"7","author":"Castell","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.appet.2026.108729_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137299","article-title":"Effects of repeated developmental GLP-1R agonist exposure on young adult behavior and hippocampal structure in mice","volume":"808","author":"Cerroni","year":"2023","journal-title":"Neuroscience Letters"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13177","article-title":"GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis","volume":"22","author":"Chadda","year":"2021","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.appet.2026.108729_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/DMSO.S4283","article-title":"Role and development of GLP-1 receptor agonists in the management of diabetes","volume":"2","author":"Chia","year":"2009","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib29","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dom.16162","article-title":"Weight loss and body composition after compounded semaglutide treatment in a real world setting","volume":"27","author":"Chun","year":"2025","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(99)00312-3","article-title":"C-reactive protein concentration in children: Relationship to adiposity and other cardiovascular risk factors","volume":"149","author":"Cook","year":"2000","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib31","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2023.612","article-title":"Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action","volume":"7","author":"Cooper","year":"2023","journal-title":"Journal of Clinical and Translational Science"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/oby.23633","article-title":"GLP-1\/Glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: A randomized trial","volume":"31","author":"Corbin","year":"2023","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/medicina58020224","article-title":"The impact of GLP1 agonists on bone metabolism: A systematic review","volume":"58","author":"Daniilopoulou","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.appet.2026.108729_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2016.10.076","article-title":"Liraglutide in an adolescent population with obesity: A randomized, double-blind, placebo-controlled 5-Week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12-17 years","volume":"181","author":"Danne","year":"2017","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15374416.2023.2251164","article-title":"Evidence base update on behavioral treatments for overweight and obesity in children and adolescents","volume":"52","author":"Davison","year":"2023","journal-title":"Journal of Clinical Child and Adolescent Psychology"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00431-025-06102-y","article-title":"Emerging cardiovascular risk factors in childhood and adolescence: A narrative review","volume":"184","author":"De Blas-Zapata","year":"2025","journal-title":"European Journal of Pediatrics"},{"issue":"9","key":"10.1016\/j.appet.2026.108729_bib37","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib38","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41366-018-0230-y","article-title":"Interventions for treating children and adolescents with overweight and obesity: An overview of Cochrane reviews","volume":"42","author":"Ells","year":"2018","journal-title":"International Journal of Obesity"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib39","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from Guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0005-7894(82)80022-1","article-title":"A comparison of lifestyle change and programmed aerobic exercise on weight and fitness changes in obese children","volume":"13","author":"Epstein","year":"1982","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.appet.2026.108729_bib41","series-title":"Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction [Center for Drug Evaluation and Research]","year":"2025"},{"key":"10.1016\/j.appet.2026.108729_bib42","series-title":"FDA approves weight management drug for patients aged 12 and older","year":"2021"},{"key":"10.1016\/j.appet.2026.108729_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2023.1293926","article-title":"The benefits of GLP1 receptors in cardiovascular diseases","volume":"4","author":"Ferhatbegovi\u0107","year":"2023","journal-title":"Frontiers in Clinical Diabetes and Healthcare"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to <12 years of age with obesity\u2014A randomized trial","volume":"392","author":"Fox","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/oby.23395","article-title":"Exenatide for weight loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial","volume":"30","author":"Fox","year":"2022","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib47","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2025-071202","article-title":"Children with obesity are not little adults with obesity","volume":"156","author":"Fox","year":"2025","journal-title":"Pediatrics"},{"issue":"20","key":"10.1016\/j.appet.2026.108729_bib48","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jacc.2025.08.027","article-title":"Cardiovascular effects and tolerability of GLP-1 receptor agonists","volume":"86","author":"Galli","year":"2025","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.atherosclerosis.2007.06.023","article-title":"Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children","volume":"197","author":"Giannini","year":"2008","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.appet.2026.108729_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"key":"10.1016\/j.appet.2026.108729_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuroimage.2013.09.073","article-title":"The influence of puberty on subcortical brain development","volume":"88","author":"Goddings","year":"2014","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib52","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2014-2173","article-title":"Optimizing bone health in children and adolescents","volume":"134","author":"Golden","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.appet.2026.108729_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.795224","article-title":"Treatment adherence to injectable treatments in pediatric growth hormone deficiency compared with injectable treatments in other chronic pediatric conditions: A systematic literature review","volume":"13","author":"Gomez","year":"2022","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120410","article-title":"Influence of childhood excess weight on cognitive, behavioural and emotional outcomes","volume":"393","author":"Gonz\u00e1lez-Palacios","year":"2026","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cvr\/cvq271","article-title":"GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons","volume":"89","author":"Griffioen","year":"2011","journal-title":"Cardiovascular Research"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib56","article-title":"Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl","year":"2023","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib57","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like Peptide-1-(7\u201336)Amide is transformed to glucagon-like Peptide-1-(9\u201336)Amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine Intestine1","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: A randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13193","volume":"20","author":"Henderson","year":"2025","journal-title":"Pediatric Obesity"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib60","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/mp.2017.91","article-title":"A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling","volume":"23","author":"Hsu","year":"2018","journal-title":"Molecular Psychiatry"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/XCE.0000000000000346","article-title":"Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists \u2013 What is the role of weight reduction?","volume":"14","author":"Jacob","year":"2025","journal-title":"Cardiovascular Endocrinology & Metabolism"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/dc11-1281","article-title":"Age before stage: Insulin resistance rises before the onset of puberty","volume":"35","author":"Jeffery","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: A secondary analysis of a randomized clinical trial","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Network Open"},{"issue":"n\/a","key":"10.1016\/j.appet.2026.108729_bib65","article-title":"Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet-induced obesity","author":"Jeromson","year":"2025","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.appet.2026.108729_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102505","article-title":"Cognitive functioning in adolescents with severe obesity undergoing bariatric surgery or intensive non-surgical treatment in Sweden (AMOS2): A multicentre, open-label, randomised controlled trial","volume":"70","author":"J\u00e4rvholm","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib66","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1542\/peds.2008-3727","article-title":"Family-based treatment of severe pediatric obesity: Randomized, controlled trial","volume":"124","author":"Kalarchian","year":"2009","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib67","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1210\/jc.2006-2411","article-title":"Behavioral interventions to prevent childhood obesity: A systematic review and metaanalyses of randomized trials","volume":"93","author":"Kamath","year":"2008","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"8","key":"10.1016\/j.appet.2026.108729_bib68","article-title":"The antiobesity effect and safety of GLP-1 receptor agonist in overweight\/obese adolescents without diabetes mellitus: A systematic review and meta-analysis","volume":"16","author":"Katole","year":"2024","journal-title":"Cureus"},{"issue":"22","key":"10.1016\/j.appet.2026.108729_bib69","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib70","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/oby.2011.337","article-title":"Exenatide as a weight-loss therapy in extreme pediatric obesity A randomized, controlled pilot study","volume":"20","author":"Kelly","year":"2012","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamapediatrics.2013.1045","article-title":"The effect of glucagon-like Peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: A randomized, placebo-controlled, clinical trial","volume":"167","author":"Kelly","year":"2013","journal-title":"JAMA Pediatrics"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11892-016-0751-5","article-title":"Insulin resistance of puberty","volume":"16","author":"Kelsey","year":"2016","journal-title":"Current Diabetes Reports"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib73","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamapediatrics.2024.3812","article-title":"Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists","volume":"178","author":"Kerem","year":"2024","journal-title":"JAMA Pediatrics"},{"issue":"23","key":"10.1016\/j.appet.2026.108729_bib74","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","article-title":"The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness","volume":"22","author":"Kinzig","year":"2002","journal-title":"Journal of Neuroscience"},{"issue":"19","key":"10.1016\/j.appet.2026.108729_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159863","article-title":"Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial","volume":"7","author":"Klausen","year":"2022","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2337\/diacare.27.2.378","article-title":"Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: A longitudinal study","volume":"27","author":"Klein","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.appet.2026.108729_bib77","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/dia.2013.0366","article-title":"Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: A randomized, double-blind, placebo-controlled trial","volume":"16","author":"Klein","year":"2014","journal-title":"Diabetes Technology & Therapeutics"},{"key":"10.1016\/j.appet.2026.108729_bib78","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7420a1","article-title":"Prescriptions for obesity medications among adolescents aged 12\u201317 years with obesity\u2014United States, 2018\u20132023","volume":"74","author":"Kompaniyets","year":"2025","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5603\/EP.a2021.0031","article-title":"Evaluation of the risk of fracture in type 2 diabetes mellitus patients with incretins: An updated meta-analysis","volume":"72","author":"Kong","year":"2021","journal-title":"Endokrynologia Polska"},{"key":"10.1016\/j.appet.2026.108729_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2023.103925","article-title":"GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling","volume":"3","author":"Kooij","year":"2024","journal-title":"Neuroscience Applied"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75965-2","article-title":"The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy","volume":"14","author":"Kornelius","year":"2024","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib82","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamapediatrics.2025.3243","article-title":"Efficacy and safety of GLP-1 RAs in children and adolescents with obesity or type 2 diabetes: A systematic review and meta-analysis","volume":"179","author":"Kotecha","year":"2025","journal-title":"JAMA Pediatrics"},{"issue":"23","key":"10.1016\/j.appet.2026.108729_bib83","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.3390\/nu17233735","article-title":"Beyond weight loss: GLP-1 usage and appetite regulation in the context of eating disorders and psychosocial processes","volume":"17","author":"Krug","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/nyas.15278","article-title":"Behavior-change lifestyle interventions for the treatment of obesity in children and adolescents: A scoping review","volume":"1543","author":"Li","year":"2025","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"18","key":"10.1016\/j.appet.2026.108729_bib84","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like Peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.appet.2026.108729_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110570","article-title":"Adolescent nutritional influences on the brain: Implications for eating behaviors","volume":"278","author":"Lazzaro","year":"2025","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.appet.2026.108729_bib86","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.2024.7112","article-title":"Dispensing of glucagon-like Peptide-1 receptor agonists to adolescents and young adults, 2020-2023","volume":"331","author":"Lee","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib89","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT\u20101 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-016-0490-6","article-title":"Differential effects of glucagon-like peptide-1 receptor agonists on heart rate","volume":"16","author":"Lorenz","year":"2017","journal-title":"Cardiovascular Diabetology"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib91","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cvr\/cvae120","article-title":"Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node","volume":"120","author":"Lubberding","year":"2024","journal-title":"Cardiovascular Research"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib92","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/jcem-57-2-268","article-title":"Somatomedins in adolescence: A cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels","volume":"57","author":"Luna","year":"1983","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"18","key":"10.1016\/j.appet.2026.108729_bib93","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy weight loss maintenance with exercise, liraglutide, or both combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib94","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/joim.13547","article-title":"Pediatric obesity\u2014Long\u2010term consequences and effect of weight loss","volume":"292","author":"Marcus","year":"2022","journal-title":"Journal of Internal Medicine"},{"issue":"19","key":"10.1016\/j.appet.2026.108729_bib95","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12495","article-title":"Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics","volume":"14","author":"Mastrandrea","year":"2019","journal-title":"Pediatric Obesity"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib98","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/nu13072473","article-title":"Weight loss strategies and the risk of skeletal muscle mass loss","volume":"13","author":"McCarthy","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib99","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: A substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib100","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1210\/jc.2006-2409","article-title":"Treatment of pediatric obesity: A systematic review and meta-analysis of randomized trials","volume":"93","author":"McGovern","year":"2008","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib101","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000499386","article-title":"Effect of obesity on cognitive function among school adolescents: A cross-sectional study","volume":"12","author":"Meo","year":"2019","journal-title":"Obesity Facts"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"Journal of Comparative Neurology"},{"issue":"10","key":"10.1016\/j.appet.2026.108729_bib103","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.39887","article-title":"Characterizing GLP-1 receptor agonist use in preadolescent and adolescent populations","volume":"7","author":"Miller","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.appet.2026.108729_bib104","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.2147\/DDDT.S506957","article-title":"A comprehensive review on the pharmacokinetics and drug\u2212drug interactions of approved GLP-1 receptor agonists and a dual GLP-1\/GIP receptor agonist","volume":"19","author":"Min","year":"2025","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.appet.2026.108729_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115290","article-title":"Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls","volume":"134","author":"Misra","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.appet.2026.108729_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1069164","article-title":"Association of childhood and adolescence obesity with incidence and mortality of adulthood cancers. A systematic review and meta-analysis","volume":"14","author":"Mohammadian Khonsari","year":"2023","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib107","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fnins.2019.01108","article-title":"Examining adolescence as a sensitive period for high-fat, high-sugar diet exposure: A systematic review of the animal literature","volume":"13","author":"Murray","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"9","key":"10.1016\/j.appet.2026.108729_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102834","article-title":"Semaglutide and cancer: A systematic review and meta-analysis","volume":"17","author":"Nagendra","year":"2023","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research Reviews"},{"issue":"S4","key":"10.1016\/j.appet.2026.108729_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.appet.2026.108729_bib110","article-title":"GLP-1 selectively enhances tonic GABAA receptor-mediated currents in mouse dentate gyrus granule cells of the ventral hippocampus","volume":"19","author":"Netsyk","year":"2025","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib111","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib112","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.1152\/ajpendo.00118.2010","article-title":"Insulin resistance syndrome blunts the mitochondrial anabolic response following resistance exercise","volume":"299","author":"Nilsson","year":"2010","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/1028415X.2017.1378851","article-title":"Early life sugar consumption has long-term negative effects on memory function in male rats","volume":"22","author":"Noble","year":"2019","journal-title":"Nutritional Neuroscience"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01309-7","article-title":"Gut microbial taxa elevated by dietary sugar disrupt memory function","volume":"11","author":"Noble","year":"2021","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.appet.2026.108729_bib114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cobeha.2015.11.014","article-title":"Early life exposure to obesogenic diets and learning and memory dysfunction","volume":"9","author":"Noble","year":"2016","journal-title":"Current Opinion in Behavioral Sciences"},{"issue":"14","key":"10.1016\/j.appet.2026.108729_bib117","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/jama.288.14.1728","article-title":"Prevalence and trends in overweight among US children and adolescents, 1999-2000","volume":"288","author":"Ogden","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib118","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, As well As synchronizing the onset of puberty in female rats","volume":"156","author":"Outeiri\u00f1o-Iglesias","year":"2015","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib119","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11010-023-04784-2","article-title":"Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression","volume":"479","author":"Pan","year":"2024","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.2047-6310.2012.00139.x","article-title":"Change in body composition during a weight loss trial in obese adolescents","volume":"9","author":"Parks","year":"2014","journal-title":"Pediatric Obesity"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of Liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib122","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00592-024-02392-0","article-title":"A qualitative study of the mental health outcomes in people being treated for obesity and type 2 diabetes with glucagon-like peptide-1 receptor agonists","volume":"62","author":"Pierret","year":"2025","journal-title":"Acta Diabetologica"},{"issue":"8","key":"10.1016\/j.appet.2026.108729_bib123","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","article-title":"Implications of low muscle mass across the continuum of care: A narrative review","volume":"50","author":"Prado","year":"2018","journal-title":"Annals of Medicine"},{"issue":"10192","key":"10.1016\/j.appet.2026.108729_bib124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(19)31271-1","article-title":"Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): A randomised, double-blind, phase 3a trial","volume":"394","author":"Pratley","year":"2019","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1079\/PNS2006519","article-title":"Symposium on \u2018Nutrition and health in children and adolescents\u2019 session 1: Nutrition in growth and development","volume":"65","author":"Prentice","year":"2006","journal-title":"Proceedings of the Nutrition Society"},{"key":"10.1016\/j.appet.2026.108729_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.704647","article-title":"The impact of diet and physical activity on bone health in children and adolescents","volume":"12","author":"Proia","year":"2021","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib127","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/dom.15386","article-title":"Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial","volume":"26","author":"Qin","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like Peptide-1 analog, reduces body weight and food intake in Obese candy-fed rats, whereas a dipeptidyl Peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib129","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/biomedicines13061504","article-title":"A review of the relationship between insulin and bone health","volume":"13","author":"Ravindran","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.appet.2026.108729_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2025.03.011","article-title":"Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation","author":"Ravussin","year":"2025","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.appet.2026.108729_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2025.1579961","article-title":"GLP-1 receptor agonists and pancreatic beta cell apoptosis in diabetes mellitus: A systematic review and meta-analysis of preclinical studies","volume":"6","author":"Rea","year":"2025","journal-title":"Frontiers in Clinical Diabetes and Healthcare"},{"key":"10.1016\/j.appet.2026.108729_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1386542","article-title":"Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus","volume":"15","author":"Rodr\u00edguez Jim\u00e9nez","year":"2024","journal-title":"Frontiers in Endocrinology"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib133","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jped.2014.03.005","article-title":"Insulin resistance in obese children and adolescents","volume":"90","author":"Romualdo","year":"2014","journal-title":"Jornal de Pediatria"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib134","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes","volume":"393","author":"Rosenstock","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc09-1203","article-title":"Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"issue":"0","key":"10.1016\/j.appet.2026.108729_bib136","article-title":"Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): A multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial","volume":"0","author":"Rosenstock","year":"2026","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib137","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"The Lancet. Diabetes & Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib139","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2021.05.009","article-title":"Safety and efficacy of glucagon-like Peptide-1 receptor agonists in children and adolescents with obesity: A meta-analysis","volume":"236","author":"Ryan","year":"2021","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.appet.2026.108729_bib138","doi-asserted-by":"crossref","DOI":"10.1007\/s40592-025-00280-z","article-title":"The ethics of wegovy for children: The argument from too many unknowns","author":"Ryan","year":"2026","journal-title":"Monash Bioethics Review"},{"key":"10.1016\/j.appet.2026.108729_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1694170","article-title":"Effects of exercise on cognitive function in children and adolescents with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Li","year":"2025","journal-title":"Frontiers in Public Health"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/dom.70198","article-title":"Psychiatric effects of GLP\u20101 receptor agonists: A systematic review of emerging evidence","volume":"28","author":"Sa","year":"2026","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.appet.2026.108729_bib141","article-title":"Comparative efficacy of metabolic\/bariatric surgery versus GLP-1 receptor agonists: A network meta-analysis of randomized controlled trials","author":"Sabatella","year":"2025","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.appet.2026.108729_bib142","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1542\/peds.2010-0697","article-title":"Long-term results of an obesity program in an ethnically diverse pediatric population","volume":"127","author":"Savoye","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.orcp.2025.01.009","article-title":"Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review","volume":"19","author":"Schmidt","year":"2025","journal-title":"Obesity Research & Clinical Practice"},{"key":"10.1016\/j.appet.2026.108729_bib144","first-page":"1","article-title":"Metabolic outcomes and safety of GLP-1 receptor agonists in children and adolescents with obesity: A systematic review and meta-analysis","author":"Sedenho-Prado","year":"2025","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.appet.2026.108729_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"0","author":"Semple","year":"2013","journal-title":"Progress in Neurobiology"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib146","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/pir.2024-006455","article-title":"Glucagon-like Peptide-1 agonists and pediatric obesity","volume":"46","author":"Shanti Vaidya","year":"2025","journal-title":"Pediatrics in Review"},{"key":"10.1016\/j.appet.2026.108729_bib147","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuroimage.2015.07.083","article-title":"Neural networks involved in adolescent reward processing: An activation likelihood estimation meta-analysis of functional neuroimaging studies","volume":"122","author":"Silverman","year":"2015","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/obr.12334","article-title":"Predicting adult obesity from childhood obesity: A systematic review and meta-analysis","volume":"17","author":"Simmonds","year":"2016","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.appet.2026.108729_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: Implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Frontiers in Neuroscience"},{"issue":"Suppl 1","key":"10.1016\/j.appet.2026.108729_bib150","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.4103\/2230-8210.145073","article-title":"Nutrition and pubertal development","volume":"18","author":"Soliman","year":"2014","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.appet.2026.108729_bib151","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11892-018-1062-9","article-title":"The impact of childhood and adolescent obesity on cardiovascular risk in adulthood: A systematic review","volume":"18","author":"Sommer","year":"2018","journal-title":"Current Diabetes Reports"},{"issue":"2 0 2","key":"10.1016\/j.appet.2026.108729_bib152","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jadohealth.2012.05.006","article-title":"Adolescent neurodevelopment","volume":"52","author":"Spear","year":"2013","journal-title":"Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine"},{"key":"10.1016\/j.appet.2026.108729_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1293093","article-title":"Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control","volume":"14","author":"Stenlid","year":"2023","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib154","author":"Stierman"},{"issue":"6","key":"10.1016\/j.appet.2026.108729_bib155","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/clinem\/dgab098","article-title":"Fasting plasma GLP-1 is associated with overweight\/obesity and cardiometabolic risk factors in children and adolescents","volume":"106","author":"Stinson","year":"2021","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib156","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes","volume":"381","author":"Tamborlane","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"9_Supplement_1","key":"10.1016\/j.appet.2026.108729_bib157","article-title":"Liraglutide and semaglutide attenuate inflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and interleukin-6: Possible mechanism of decreasing cardiovascular risk in diabetes mellitus","volume":"73","author":"Tan","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib158","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13113","article-title":"Pharmacological interventions for the management of children and adolescents living with obesity\u2014An update of a Cochrane systematic review with meta-analyses","volume":"19","author":"Torbahn","year":"2024","journal-title":"Pediatric Obesity"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib159","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cen.15133","article-title":"Anti\u2010obesity medication in the management of children and adolescents with obesity: Recent developments and research gaps","volume":"102","author":"Torbahn","year":"2025","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.appet.2026.108729_bib160","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821997320","article-title":"GLP-1 receptor agonists: An updated review of head-to-head clinical studies","volume":"12","author":"Trujillo","year":"2021","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib161","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1080\/1028415X.2021.1980697","article-title":"Early life Western diet-induced memory impairments and gut microbiome changes in female rats are long-lasting despite healthy dietary intervention","volume":"25","author":"Tsan","year":"2022","journal-title":"Nutritional Neuroscience"},{"issue":"5","key":"10.1016\/j.appet.2026.108729_bib162","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn.4540","article-title":"GLP-1 acts on habenular avoidance circuits to control nicotine intake","volume":"20","author":"Tuesta","year":"2017","journal-title":"Nature Neuroscience"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib163","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc19-1988","article-title":"Adolescent obesity and early-onset type 2 diabetes","volume":"43","author":"Twig","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib164","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates Appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.appet.2026.108729_bib165","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/dom.12506","article-title":"Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans","volume":"17","author":"van Bloemendaal","year":"2015","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.appet.2026.108729_bib166","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neubiorev.2016.06.037","article-title":"What motivates adolescents? Neural responses to rewards and their influence on adolescents' risk taking, learning, and cognitive control","volume":"70","author":"van Duijvenvoorde","year":"2016","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib167","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41390-018-0047-3","article-title":"Improved cognitive functioning in obese adolescents after a 30-week inpatient weight loss program","volume":"84","author":"Vantieghem","year":"2018","journal-title":"Pediatric Research"},{"issue":"n\/a","key":"10.1016\/j.appet.2026.108729_bib168","article-title":"Effects of glucagon-like Peptide-1 receptor agonists (Mono and combination therapy) on energy expenditure: A scoping review","author":"Vieira","year":"2026","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.appet.2026.108729_bib169","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fendo.2011.00032","article-title":"The intricate role of growth hormone in metabolism","volume":"2","author":"Vijayakumar","year":"2011","journal-title":"Frontiers in Endocrinology"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib170","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.3390\/nu14122414","article-title":"Once-weekly semaglutide induces an early improvement in body composition in patients with type 2 diabetes: A 26-Week prospective real-life study","volume":"14","author":"Volpe","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib171","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41591-023-02672-2","article-title":"Association of semaglutide with risk of suicidal ideation in a real-world cohort","volume":"30","author":"Wang","year":"2024","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib172","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.53323","article-title":"Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists","volume":"9","author":"Wang","year":"2026","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib173","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/ENDO:17:1:43","article-title":"Adolescence","volume":"17","author":"Weaver","year":"2002","journal-title":"Endocrine"},{"issue":"24","key":"10.1016\/j.appet.2026.108729_bib174","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.appet.2026.108729_bib175","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12624","article-title":"A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity","volume":"15","author":"Weghuber","year":"2020","journal-title":"Pediatric Obesity"},{"issue":"23","key":"10.1016\/j.appet.2026.108729_bib176","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"0","key":"10.1016\/j.appet.2026.108729_bib177","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment","volume":"0","author":"Wharton","year":"2025","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8529(18)30279-2","article-title":"Physical changes of puberty","volume":"20","author":"Wheeler","year":"1991","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib179","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/oby.23622","article-title":"Real-world weight loss effectiveness of GLP-1 agonists among patients with type 2 diabetes: A retrospective cohort study","volume":"31","author":"White","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.appet.2026.108729_bib180","series-title":"WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults","year":"2025"},{"issue":"8","key":"10.1016\/j.appet.2026.108729_bib183","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"11","key":"10.1016\/j.appet.2026.108729_bib181","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.appet.2026.108729_bib182","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1210\/jendso\/bvab048.030","article-title":"Impact of semaglutide on body composition in adults with overweight or obesity: Exploratory analysis of the STEP 1 study","volume":"5","author":"Wilding","year":"2021","journal-title":"Journal of the Endocrine Society"},{"issue":"2","key":"10.1016\/j.appet.2026.108729_bib184","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.appet.2026.108729_bib185","unstructured":"World Health Organization. (n.d.). Obesity and overweight. World Health Organization. Retrieved January 30, 2025, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.appet.2026.108729_bib186","article-title":"Adherence and effectiveness of liraglutide in adolescents with obesity","author":"Yaron","year":"2025","journal-title":"Childhood Obesity"},{"key":"10.1016\/j.appet.2026.108729_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177966","article-title":"The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight\/obesity: An umbrella review of systematic reviews and meta-analyses","volume":"1003","author":"Zamanian","year":"2025","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.appet.2026.108729_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.724030","article-title":"Anatomical and functional characterization of central amygdala glucagon-like peptide 1 receptor expressing neurons","volume":"15","author":"Zeng","year":"2021","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"1","key":"10.1016\/j.appet.2026.108729_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"10.1016\/j.appet.2026.108729_bib190","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3892\/etm.2017.4129","article-title":"The effects of GLP-1 analogues on pre-diabetes of the children","volume":"13","author":"Zhou","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"12","key":"10.1016\/j.appet.2026.108729_bib191","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/dc19-0898","article-title":"Efficacy, safety, and tolerability of oral semaglutide versus placebo added to insulin with or without metformin in patients with type 2 diabetes: The PIONEER 8 trial","volume":"42","author":"Zinman","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Appetite"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195666326002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195666326002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:27:21Z","timestamp":1788787641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195666326002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":190,"alternative-id":["S0195666326002916"],"URL":"https:\/\/doi.org\/10.1016\/j.appet.2026.108729","relation":{},"ISSN":["0195-6663"],"issn-type":[{"value":"0195-6663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period","name":"articletitle","label":"Article Title"},{"value":"Appetite","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.appet.2026.108729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108729"}}